Detalhe da pesquisa
1.
Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis.
Liver Int
; 43(8): 1714-1728, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37057737
2.
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.
J Hepatol
; 76(1): 11-24, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555423
3.
The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis.
Hepatology
; 73(2): 606-624, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329085
4.
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
J Hepatol
; 73(1): 17-25, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147361
5.
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
Clin Gastroenterol Hepatol
; 18(1): 216-225.e5, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195161
6.
Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
Liver Int
; 40(10): 2553-2567, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32432822
7.
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients.
Liver Int
; 40(9): 2182-2193, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559006
8.
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.
J Hepatol
; 70(3): 494-500, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30389552
9.
Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis.
Am J Pathol
; 188(12): 2800-2810, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30248338
10.
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. / Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH.
Gastroenterol Hepatol
; 42(10): 657-676, 2019 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31771785
11.
A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
Hepatology
; 65(3): 950-968, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27880981
12.
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. / Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica.
Gastroenterol Hepatol
; 41(5): 328-349, 2018 May.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-29631866
13.
Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver.
J Lipid Res
; 58(9): 1903-1915, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754826
14.
Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Biochim Biophys Acta
; 1862(9): 1710-23, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27321932
15.
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Severe Infection: Post Hoc Analysis Is Warranted.
Clin Infect Dis
; 72(11): e922, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005937
16.
Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
J Hepatol
; 65(4): 748-757, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245430
17.
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
J Hepatol
; 64(2): 409-418, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394163
18.
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
J Gastroenterol Hepatol
; 31(9): 1611-8, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26946071
19.
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
J Hepatol
; 62(3): 673-81, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25457203
20.
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).
J Hepatol
; 73(3): 740-741, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654856